What Is My Clinic Actually Worth? Valuing a UAE Medical Practice Beyond the Real Estate
A property valuation tells you what the premises are worth, not what your practice is worth. How UAE buyers price clinics, why goodwill decides your multiple, and what to fix before you sell.

When an owner asks what their clinic is worth, they are usually asking one question and being answered with a different one. A property valuer will tell you what the premises are worth. That number is real, and it is not the value of your business.
The gap between those two figures is where most UAE clinic sales are won or lost.
Two numbers, one asset
A healthcare facility carries a property value and an operating business value, and they behave differently. The premises are priced against comparable commercial space. The business is priced against its earnings, its durability and how much of it survives your departure.
For a clinic with a strong patient base and insurer contracts, the business is frequently worth considerably more than the bricks. For a clinic whose revenue rests entirely on the founder, it can be worth remarkably little. Same square metres, very different outcomes.
The absence of a settled standard for valuing a medical business, as opposed to medical premises, is a genuine structural gap in this market. It is also why two advisers can hand the same owner valuations that differ by a factor of two.
How buyers actually price a UAE clinic
The multiple
UAE healthcare businesses trade in the region of six to ten times EBITDA, which sits among the highest multiple ranges in the UAE market generally. Three things support that premium:
- Licensing barriers. Entry is slow and regulated, so an operating licensed facility carries scarcity value.
- Insured demand. Mandatory health cover underwrites a baseline of paying patients.
- Consolidation appetite. Groups are actively buying, which supports pricing at the upper end for assets that fit a roll-up.
For context, healthcare services multiples globally have been normalising rather than climbing. Median enterprise value to EBITDA moderated to roughly 11.5 times in 2025, down from about 14.5 times in 2024, as credit tightened and clinician compensation costs rose. The direction of travel matters if you are timing an exit.
Normalised EBITDA, not accounting EBITDA
Buyers do not apply a multiple to the number in your management accounts. They apply it to a normalised figure, and the adjustments usually move in the buyer's favour unless you have prepared.
- An owner drawing below-market compensation inflates reported profit. Expect a market-rate salary to be deducted.
- Related-party rent below market rate will be restated upward.
- One-off items get stripped out in both directions.
- Personal expenses running through the business get removed, and their presence damages the buyer's confidence in every other line.
The goodwill question that sets your multiple
This is the single largest swing factor, and it is worth understanding precisely.
Personal goodwill attaches to an individual clinician. Patients come because of Dr. Someone specifically. It does not transfer with ownership, because the thing generating revenue is a person who is leaving.
Practice goodwill attaches to the enterprise: location, systems, brand, referral relationships, insurer panels and a team rather than an individual. It transfers, and it commands a premium.
Where revenue visibly follows named doctors, buyers respond in one of two ways. They discount the multiple, or they restructure the price as an earn-out contingent on those doctors staying. Clinics with institutional demand, a recognised brand, insurance panels, corporate contracts and team-based delivery are the ones that achieve the top of the range.
If your clinic cannot run for a month without you in it, you are selling a job, and buyers price jobs cautiously.
What moves your valuation up
- Insurer empanelment across multiple networks, with contracts documented and current
- Payer mix weighted to insured revenue, which is more predictable than cash
- Lease length, ideally with renewal rights, because a buyer inherits your security of tenure
- A clean licence with no open violations, appeals or suspensions
- Team-based care where no single departure removes more than a modest share of revenue
- Recurring and programmatic revenue, such as chronic disease management or corporate screening contracts
- Documented processes, because transferability is what a buyer is paying for
What moves it down
- Revenue concentrated in one clinician, particularly the departing owner
- A short or non-assignable lease
- Elevated claim rejection rates, which signal weak documentation discipline
- Fit-out that no longer meets current standards, since the buyer inherits the remediation
- Records that cannot withstand diligence, which reduces price and often ends processes entirely
An illustration
The figures below are illustrative only, chosen to show how the mechanics interact rather than to predict any particular outcome.
Take a polyclinic reporting AED 2,000,000 of profit. The owner pays themselves AED 300,000 against a market rate of AED 600,000 for the equivalent clinical and management role. Normalised EBITDA therefore falls to AED 1,700,000.
Two scenarios diverge from there. In the first, three specialists share revenue reasonably evenly, the clinic holds five insurer contracts and eight years remain on the lease. That profile invites the upper part of the range. In the second, seventy per cent of revenue follows the departing owner and two years remain on the lease. That profile invites the lower part, and quite possibly an earn-out rather than cash at completion.
The underlying business is identical in size. The transferability is not, and transferability is what determines the multiple.
What to do in the twelve months before you sell
Most of the value uplift available to a seller is operational, not negotiational, and it takes time to establish.
- Distribute clinical load so no individual carries a disproportionate share of revenue
- Renew or extend the lease, and confirm assignment is permitted
- Close out any open regulatory items so the licence is demonstrably clean
- Add or renew insurer contracts, and file the paperwork properly
- Move personal expenses out of the business and let a clean period accumulate
- Write down the processes that currently exist only in your head
A seller who does this arrives at the table with an asset that survives diligence. A seller who does not spends the process defending the number they started with.

Written by
Dr. Asmaa Al-NajjarFounder, MedProp
Dr. Asmaa Al-Najjar is the founder of MedProp, the strategic arm of MedStream. She combines a medical background with strategic economic expertise, and established MedProp to bridge traditional healthcare sectors with the future of digital health and investment across the UAE.

